This is a preprint.
Machine learning for estimating and comparing clinical rules for treating diarrheal illness with antibiotics
- PMID: 39830249
- PMCID: PMC11741478
- DOI: 10.1101/2025.01.10.25320357
Machine learning for estimating and comparing clinical rules for treating diarrheal illness with antibiotics
Abstract
Acute diarrheal disease is one of the leading causes of death in children under age 5, disproportionately impacting children in low-resource settings. Many of these cases are caused by bacteria and therefore could respond to antibiotic treatment; however, the benefits of widely prescribing antibiotics must be weighed against the risks for the emergence of microbial resistance. These challenges present the opportunity for developing individualized treatment guidelines for diarrheal disease. In this study, we utilize a framework for the creation and evaluation of individualized treatment rules that leverage diagnostic and other clinical information to recommend antibiotic treatment to children with watery diarrhea. In contrast to many applications of pipelines for creating and evaluating treatment rules, we (i) explicitly consider creating rules that limit the proportion of children treated under a rule, to limit risks for overtreatment and the emergence of microbial resistance and (ii) propose methods to compare the performance of rules based on different sets of input covariates, which allows for quantification of the impact of measuring additional diagnostic biomarkers in clinical settings. We use a nested cross validation procedure that makes use of ensemble machine learning and doubly-robust estimation approach to derive, evaluate, and compare rules. We demonstrate that our proposed method yields appropriate inference in a realistic simulation study and apply our method to a real-data analysis of the AntiBiotics for Children with severe Diarrhea (ABCD) trial.
Keywords: causal inference; cross-validation; doubly robust learner; enteric disease; individualized treatment rules.
Conflict of interest statement
CONFLICT OF INTEREST The authors declare no potential conflict of interests.
Figures
Similar articles
-
A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol.Trials. 2020 Jan 13;21(1):71. doi: 10.1186/s13063-019-3829-y. Trials. 2020. PMID: 31931848 Free PMC article.
-
Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.Biometrika. 2015 Mar 1;102(1):151-168. doi: 10.1093/biomet/asu050. Biometrika. 2015. PMID: 25937641 Free PMC article.
-
Estimation and evaluation of linear individualized treatment rules to guarantee performance.Biometrics. 2018 Jun;74(2):517-528. doi: 10.1111/biom.12773. Epub 2017 Sep 28. Biometrics. 2018. PMID: 28960239 Free PMC article.
-
Comprehensive analysis of rule formalisms to represent clinical guidelines: Selection criteria and case study on antibiotic clinical guidelines.Artif Intell Med. 2020 Mar;103:101741. doi: 10.1016/j.artmed.2019.101741. Epub 2020 Jan 9. Artif Intell Med. 2020. PMID: 31928849 Review.
-
Taxonomy of hybrid architectures involving rule-based reasoning and machine learning in clinical decision systems: A scoping review.J Biomed Inform. 2023 Aug;144:104428. doi: 10.1016/j.jbi.2023.104428. Epub 2023 Jun 22. J Biomed Inform. 2023. PMID: 37355025
References
-
- Troeger C, Blacker BF, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 2018;18(11):1211–1228. doi: 10.1016/S1473-3099(18)30362-1 - DOI - PMC - PubMed
-
- Pavlinac PB, Platts-Mills JA, Liu J, et al. Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With SevereDiarrhea (ABCD) Trial Incorporating Molecular Diagnostics. The Journal of Infectious Diseases. 2023:jiad252. doi: 10.1093/infdis/jiad252 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources